Additional assistance necessary for patients prescribed specialty therapies.
Julia Laurin
Advertisement
Articles by Julia Laurin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Launch is Just the Beginning: Rare Disease Care Requires Durability
2
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
3
FDA Pauses Release of New CRL’s Following Citizen’s Petition
4
Novartis to Layoff 322 NJ Employees: Report
5